UC San Diego researchers uncover enzyme behind cancer genome chaos, pointing to potential therapies for aggressive tumors.

A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch ...

Patients with stage I or II hormone receptor-negative breast cancer do not benefit from preoperative breast MRI, according to ...

Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following ...

University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...

The findings come out of the UH Cancer Center, Hawaiʻi’s only National Cancer Institute-designated cancer center. Based in Kakaʻako, the center directly employs more than 300 faculty and staff and ...

Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

San Francisco Fire Department now uses non-PFAS turnout gear, funded by FEMA and its budget. The move, supported by local ...

Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell ...

San Francisco firefighters are finally getting the protective gear they were promised after years’ long research revealed ...

It's estimated that roughly 18% of all Santa Clara County cancer patients will be admitted to the Sobrato Cancer Center, ...

Air Force veteran Dan Beard beat testicular cancer with Livestrong's guidance. Now he rides, fundraises, and mentors ...